β`χΰαι 20 ξ"β

φεψϊ ξϊο

PER OS

ξιπεο

Tablets

ωιξεω αϊψετδ

Jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis.

ξρτψ ψιωεν

149 87 33750 00

ιφψο

Novartis Pharma Stein Ag, Switzerland

ϊεχσ ψιωιεο μϊψετδ

05/2013 - 04/2018

• δηξψδ μςμεο
• ςμεο μφψλο
• ςμεο μψετΰ

δερτϊ ϊβεαδ ηγωδ ων * λεϊψϊ * ςζεψ μπε μεεγΰ ωΰϊδ μΰ ψεαεθ δϊβεαδ ωμκ χιωεψιν ιδτλε αΰετο ΰεθεξθι μμηιφιν   αωμιηϊ ϊβεαδ ΰπι ξχαμ ΰϊ ϊπΰι δωιξεω αΰϊψ.